Verification register Bio, Health & Neuro
Current reading
The readiness gap, in one scan
AI-assisted assembly · derived results
- Claimed
- 40
- Reported
- 35
- Verified
- 31
- Gap
- +9
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed minus verified
Evidence strength Strong
Decision
What the current evidence supports
Human editorial judgment · 2026-06-28
Too early to adopt
- Why
- This is the first in vivo prime-editing CTA clearance — a notable platform milestone — but there is zero human data, a constrained cash runway, and single-mutation scope, so it is a watch-list item, not an adoptable capability.
- Next
- Wait for the first-in-human safety/biological-activity readout in 2027 (copper efflux via 64Cu PET, ceruloplasmin, urinary copper) before treating in vivo prime editing as clinically de-risked.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 7
- Tier 1
- 0
- Tier 2
- 2
- Tier 3
- 5
- Supports
- 1
- Contradicts
- 3
- Context
- 3
- Latest observed
- 2026-06-18
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
This is the initial public reading. No earlier readiness change is recorded.